{"id":"NCT00558428","sponsor":"Boehringer Ingelheim","briefTitle":"Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension","officialTitle":"An Eight-week Randomized, 4-arm, Double-blind Study to Compare the Efficacy and Safety of Combinations of Telmisartan 40mg + Amlodipine 5mg Versus Telmisartan 80mg + Amlodipine 5mg Versus Amlodipine 5mg Versus Amlodipine 10mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Amlodipine 5mg Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2008-09","completion":null,"firstPosted":"2007-11-15","resultsPosted":"2009-12-15","lastUpdate":"2014-06-27"},"enrollment":1098,"design":{"allocation":null,"model":"PARALLEL","masking":null,"primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"fixed dose combination of telmisartan+amlodipine","otherNames":[]},{"type":"DRUG","name":"amlodipine","otherNames":[]}],"arms":[],"summary":"The primary objectives of this trial are (a) to demonstrate that the fixed-dose combination T40/A5 or the fixed-dose combination T80/A5 is superior in reducing blood pressure at eight weeks compared with A5 (b) to demonstrate that the fixed-dose combination T40/A5 or the fixed-dose combination T80/A5 is not inferior in reducing blood pressure at eight weeks compared with A10 and (c) to demonstrate that the incidence of oedema on the fixed-dose combination T40/A5 pooled with the fixed-dose combination T80/A5 is superior (less oedema) to A10 in patients who fail to respond adequately to six weeks treatment with A5.","primaryOutcome":{"measure":"Change From Baseline in Trough Seated Diastolic Blood Pressure (DBP)","timeFrame":"End of study (8 weeks or last value on treatment)","effectByArm":[{"arm":"Amlodipine 5mg","deltaMin":-5.71,"sd":0.49},{"arm":"Amlodipine 10mg","deltaMin":-7.95,"sd":0.49},{"arm":"Telmisartan 40mg and Amlodipine 5mg","deltaMin":-9.35,"sd":0.48},{"arm":"Telmisartan 80mg and Amlodipine 5mg","deltaMin":-10.63,"sd":0.48}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG003","p":"<0.0001"},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG003","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":129,"countries":["Belgium","Canada","Denmark","Finland","France","Netherlands","Norway","Philippines","South Africa","South Korea","Sweden","Taiwan"]},"refs":{"pmids":[],"seeAlso":["http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/1235/1235.5_Literature.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":267},"commonTop":["Oedema peripheral"]}}